Stephen E Kirkby

Contact Information

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

PediatricsPulmonary Medicine/Lung & Lung Heart Transplant700 Children’s DrColumbus, OH 43205 (map)

Learn more about Stephen E. Kirkby

Biography

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Research

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Contact Information

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

PediatricsPulmonary Medicine/Lung & Lung Heart Transplant700 Children’s DrColumbus, OH 43205 (map)

Learn more about Stephen E. Kirkby

Biography

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Research

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Contact Information

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

PediatricsPulmonary Medicine/Lung & Lung Heart Transplant700 Children’s DrColumbus, OH 43205 (map)

Learn more about Stephen E. Kirkby

Contact Information

• Call us at:
• (614) 722-3425
• Fax us at:
• (614) 722-3426
• PediatricsPulmonary Medicine/Lung & Lung Heart Transplant700 Children’s DrColumbus, OH 43205 (map)

Learn more about Stephen E. Kirkby

Biography

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Biography

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Biography

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine. He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC. Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Stephen Kirkby, MD, is the Medical Director of the Lung and Heart-Lung Transplant Programs at Nationwide Children’s Hospital (NCH) and is an Associate Professor of Pediatrics and Internal Medicine at the Ohio State University College of Medicine. Dr. Kirkby graduated from Penn State University College of Medicine. He completed his residency training in internal medicine and pediatrics at the Ohio State University Wexner Medical Center (OSUMC) and Nationwide Children’s Hospital. He then completed fellowship training in adult pulmonary/critical care medicine and pediatric pulmonary medicine.

He is board-certified in pediatric pulmonary medicine, adult pulmonary medicine, critical care medicine and internal medicine. Dr. Kirkby serves as the Program Director of the Pediatric Pulmonary Fellowship at NCH, as well as Director of the Lung Transplant Fellowship at OSUMC.

Dr. Kirkby’s areas of research focus on clinical outcomes in lung transplantation and cystic fibrosis (CF). His main clinical interests include lung transplantation, CF and other congenital lung diseases, pulmonary hypertension in advanced lung disease, and treatment of unusual pulmonary infections.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

• Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Academic and Clinical Areas

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Academic and Clinical Areas

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

Lung and Heart-Lung Transplant

Medical Director

Transplant Program

Clinical Director

Pediatric Pulmonary Fellowship

Program Director

Advanced Lung Disease

Physician Team

Pulmonary Medicine

Physician Team

Cystic Fibrosis

Physician Team

Asthma Program

Physician Team

Internal Medicine/ Pediatrics Residency

Med-Peds Trained Faculty

Primary Department

Pediatrics

Primary Section

Pulmonary, Sleep Medicine and Cystic Fibrosis

• Lung and Heart-Lung Transplant
• Medical Director
• Transplant Program
• Clinical Director
• Pediatric Pulmonary Fellowship
• Program Director
• Advanced Lung Disease
• Physician Team
• Pulmonary Medicine
• Physician Team
• Cystic Fibrosis
• Physician Team
• Asthma Program
• Physician Team
• Internal Medicine/ Pediatrics Residency
• Med-Peds Trained Faculty
• Primary Department
• Pediatrics
• Primary Section
• Pulmonary, Sleep Medicine and Cystic Fibrosis

Research

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

Research

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

Research

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

                  Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;  

                


                  Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.

                


                  Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15;  e14593.

                


                  Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;  

                


                  Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.

                


                  Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.

                


                  Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.

                


                  Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.

                


                  Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.

                


                  Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9;  1-12.

                


                  Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

View More Publications

• Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros. 2022 Aug 22;
• Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol. 2022 Feb 27; 14: 411-419.
• Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA. Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant. 2022 Jan 15; e14593.
• Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papachristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis. Am J Gastroenterol. 2021 Oct 19;
• Gross JE, McCown MY, Okorie CUA, Bishay LC, Dy FJ, Astudillo CL, Muhlebach MS, Abu-Nassar S, Chen DY, Hossain N, Wang R, Klouda T, Martiniano SL, Lenhart-Pendergrass P, Kirkby S, Ortenberg R, McSparron JI, Wang T, Hayes MM, Çoruh B. ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS Sch. 2021 Sep; 2: 452-467.
• Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc. 2021 Sep 16; 13: 371-381.
• Ramsey ML, Lara LF, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National Trends of Hospitalizations in Cystic Fibrosis Highlight a Need for Pediatric to Adult Transition Clinics. Pancreas. 2021 May-Jun 01; 50: 704-709.
• Nafiu OO, Mpody C, Kirkby SE, Samora JB, Tobias JD. Association of Preoperative Pneumonia With Postsurgical Morbidity and Mortality in Children. Anesth Analg. 2021 May 1; 132: 1380-1388.
• Hayes D Jr, Nicholson KL, Miller R, Nance AE, Kirkby SE, Parker W, Baker PB. Quality Improvement Initiative for Assessing Allografts after Lung Transplantation. Pediatr Qual Saf. 2019 Mar-Apr; 4: e146.
• Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Sep 9; 1-12.
• Khalfoun S, Tumin D, Ghossein M, Lind M, Hayes D Jr, Kirkby S. Improved Lung Function after Sinus Surgery in Cystic Fibrosis Patients with Moderate Obstruction. Otolaryngol Head Neck Surg. 2018 Feb; 158: 381-385.

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Education

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

Date of Appointment at Nationwide Children’s Hospital: 07/01/2010

Board Certifications

Critical Care Internal Medicine Pediatric Pulmonary Medicine Pulmonary Medicine

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2010

Fellowship

Ohio State University Wexner Medical Center

Date Completed: 06/30/2010

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2005

Medical School

Pennsylvania State University

Date Completed: 05/13/2001

• Critical Care
• Internal Medicine
• Pediatric Pulmonary Medicine
• Pulmonary Medicine

Contact Information

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3425

Fax us at: (614) 722-3426

                    Pulmonary Medicine/Lung & Lung Heart Transplant700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3425
• Fax us at:
• (614) 722-3426
• Pulmonary Medicine/Lung & Lung Heart Transplant700 Children’s DrColumbus, OH 43205 (map)